Thursday, April 6, 2017

Oncogene - Table of Contents alert Volume 36 Issue 14

If you are unable to see the message below, click here to view.

Open for Submissions

npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.

Explore the benefits of submitting your manuscript.


Volume 36, Issue 14 (April 2017)

In this issue
Original Articles
Short Communication

Also new

An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research.

Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation.
Now open for submissions >>
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
A supplement to Nature Biotechnology | Nature Reviews Drug Discovery

Check out the latest issue of BioPharma Dealmakers for the latest dealmaking opportunities, and editorials on personalized cancer vaccines based on tumor-specific neoantigens, the expanding network of microbiome partnerships, and impending growth spurt of the dermatology market.

Download the issue for FREE



Translational research in neuroendocrine tumors: pitfalls and opportunities

J Capdevila, O Casanovas, R Salazar, D Castellano, A Segura, P Fuster, J Aller, R García-Carbonero, P Jimenez-Fonseca, E Grande and J P Castaño

Oncogene 2017 36: 1899-1907; advance online publication, September 19, 2016; 10.1038/onc.2016.316

Abstract | Full Text



Critical role of the POT1 OB domain in maintaining genomic stability

T K Pandita

Oncogene 2017 36: 1908-1910; advance online publication, November 21, 2016; 10.1038/onc.2016.365

Abstract | Full Text

Original Articles


OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors

L A Jung, A Gebhardt, W Koelmel, C P Ade, S Walz, J Kuper, B von Eyss, S Letschert, C Redel, L d'Artista, A Biankin, L Zender, M Sauer, E Wolf, G Evan, C Kisker and M Eilers

Oncogene 2017 36: 1911-1924; advance online publication, October 17, 2016; 10.1038/onc.2016.354

Abstract | Full Text

ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis

D H Peng, C Ungewiss, P Tong, L A Byers, J Wang, J R Canales, P A Villalobos, N Uraoka, B Mino, C Behrens, I I Wistuba, R I Han, C A Wanna, M Fahrenholtz, K J Grande-Allen, C J Creighton and D L Gibbons

Oncogene 2017 36: 1925-1938; advance online publication, October 3, 2016; 10.1038/onc.2016.358

Abstract | Full Text

Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis

P Gu, Y Wang, K K Bisht, L Wu, L Kukova, E M Smith, Y Xiao, S M Bailey, M Lei, J Nandakumar and S Chang

Oncogene 2017 36: 1939-1951; advance online publication, November 21, 2016; 10.1038/onc.2016.405

Abstract | Full Text

Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1

H Liu, H Qiu, Y Song, Y Liu, H Wang, M Lu, M Deng, Y Gu, J Yin, K Luo, Z Zhang, X Jia, G Zheng and Z He

Oncogene 2017 36: 1952-1964; advance online publication, October 3, 2016; 10.1038/onc.2016.355

Abstract | Full Text

Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma

Z Xu, F Yang, D Wei, B Liu, C Chen, Y Bao, Z Wu, D Wu, H Tan, J Li, J Wang, J Liu, S Sun, L Qu and L Wang

Oncogene 2017 36: 1965-1977; advance online publication, November 14, 2016; 10.1038/onc.2016.356

Abstract | Full Text

Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury

P-H Liao, H-H Hsu, T-S Chen, M-C Chen, C-H Day, C-C Tu, Y-M Lin, F-J Tsai, W-W Kuo and C-Y Huang

Oncogene 2017 36: 1978-1990; advance online publication, October 17, 2016; 10.1038/onc.2016.357

Abstract | Full Text

Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction

T Q Tran, X H Lowman, M A Reid, C Mendez-Dorantes, M Pan, Y Yang and M Kong

Oncogene 2017 36: 1991-2001; advance online publication, October 10, 2016; 10.1038/onc.2016.360

Abstract | Full Text

The hot-spot p53R172H mutant promotes formation of giant spermatogonia triggered by DNA damage OPEN

Y Xue, A Raharja, W Sim, E S M Wong, S A B Rahmat and D P Lane

Oncogene 2017 36: 2002-2013; advance online publication, November 21, 2016; 10.1038/onc.2016.374

Abstract | Full Text

The lack of Raf-1 kinase feedback regulation enhances antiapoptosis in cancer cells

S Q Ma, B R Cao, H Zhang, L P Luo, Y Ren, T Hu and C M Chen

Oncogene 2017 36: 2014-2022; advance online publication, November 14, 2016; 10.1038/onc.2016.384

Abstract | Full Text

Short Communication


An in vivo screening system to identify tumorigenic genes

T Ihara, Y Hosokawa, K Kumazawa, K Ishikawa, J Fujimoto, M Yamamoto, T Muramkami, N Goshima, E Ito, S Watanabe and K Semba

Oncogene 2017 36: 2023-2029; advance online publication, October 3, 2016; 10.1038/onc.2016.351

Abstract | Full Text



A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets OPEN

N A Wijetunga, M Pascual, J Tozour, F Delahaye, M Alani, M Adeyeye, A W Wolkoff, A Verma and J M Greally

Oncogene 2017 36: 2030-2044; advance online publication, October 10, 2016; 10.1038/onc.2016.340

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

nature publishing group

No comments: